Jeffrey D. Macklis

Emeritus Foundation Executive Board Member/Scientific Advisor

Professor of Stem Cell and Regenerative Biology, Harvard University, and Professor of Neurology [Neuroscience] and of Surgery [Neurosurgery], Harvard Medical School; Department of Stem Cell and Regenerative Biology, Center for Brain Science, and Harvard Stem Cell Institute, Harvard University

Brad Margus

Emeritus Foundation Executive Board Member/Scientific Advisor

Brad Margus currently serves as CEO of Genome Bridge, a non-profit spin-off of the Broad Institute of Harvard and M.I.T., building a secure, cloud-based technology platform for aggregating genomic and clinical data to improve medicine. From 2009 to 2012, as co-founder and CEO of Envoy Therapeutics, Mr. Margus employed a unique technology to discover new compounds for brain diseases and then sold the company to a global pharmaceutical company. From 2000 to 2007, Mr. Margus was co-founder and CEO of Perlegen Sciences, a leader in analyzing genetic variation that identified diagnostic markers for disease risk and drug response. Mr. Margus has been a member of numerous government advisory committees as well as corporate and non-profit boards. Besides serving on the CNS Board, he currently serves on the Boards of Second Genome (a microbiome company) and Arvinas (a cancer company), as Chairman and volunteer President of the A-T Children’s Project, and as Co-chair of the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) External Oversight Board at the NIH. He obtained his MBA from Harvard Business School.

Charles D. Pacheco

Emeritus Foundation Executive Board Member/Advisor

Charles “Chuck” Pacheco is Director of Principal and Leadership Gifts at Memorial Sloan-Kettering Cancer Center in New York, the largest and longest-operating private cancer center in the world. Over the past 30 years, Chuck has served as a senior-level fundraiser at Columbia University, Harvard Medical School, Keck Graduate Institute of Applied Sciences (Claremont Colleges) and Cal Berkeley. He also worked closely with Foundation co-founders Fia and Phil Richmond as the Foundation’s first Vice President for Development. A member of the State Bar of California, Chuck is a graduate of Stanford University and Berkeley Law (Boalt Hall).

Dr. Evan Y. Snyder, M.D., Ph.D., F.A.A.P

Foundation Scientific Advisor

Professor, Sanford-Burnham Medical Research Institute 
Director, Program in Stem Cell & Regenerative Biology
Director, Stem Cell Research Center & Core Facility
Faculty Physician, Department of Pediatrics, University of California, San Diego
Faculty, Biomedical Sciences Graduate Program, University of California, San Diego
Scientific Steering Committee, Sanford Consortium for Regenerative Medicine

Dr. William Mobley, MD, PhD

Foundation Scientific Advisor

Professor and Chair, Department of Neurosciences, University of California, San Diego School of Medicine

Professor Gary Clark, MD

Foundation Scientific Advisor

Chief, Pediatric Neurology and Developmental Neuroscience, Texas Children’s Hospital
Associate Professor, Department of Pediatrics, Neurology and Neuroscience, Baylor College of Medicine

Dr. David H. Rowitch, MD, PhD

Foundation Scientific Advisor

Professor, Pediatrics and Neurological Surgery 
Chief of Neonatology, Eli & Edyth Broad Center for Stem Cell Research and Regenerative Medicine 
University of California, San Francisco

Dr. Sidhartha Tan, MD

Foundation Scientific Advisor

Senior Attending Physician, NorthShore University Health System
Clinical Professor, Department of Pediatrics, University of Chicago Pritzker School of Medicine

Dr. Jeanne Loring, PhD

Foundation Scientific Advisor

Professor and Director, Center for Regenerative Medicine, The Scripps Research Institute

Dr. Margot Mayer-Proschel, PhD

Foundation Scientific Advisor

Associate Professor, Department of Biomedical Genetics Associate Professor, Department of Neurobiology and Anatomy University of Rochester

Dr. Robert W. Mays, PhD

Foundation Scientific Advisor

Head of Neuroscience, Senior Director of Regenerative Medicine, Athersys, Inc.